From infection to death: an overview of the pathogenesis of Visceral Leishmaniasis
CHN Costa, KP Chang, DL Costa, FVM Cunha - Pathogens, 2023 - mdpi.com
Kala-azar, also known as visceral leishmaniasis (VL), is a disease caused by Leishmania
infantum and L. donovani. Patients experience symptoms such as fever, weight loss …
infantum and L. donovani. Patients experience symptoms such as fever, weight loss …
Reverse transcription-loop-mediated isothermal amplification-CRISPR-Cas13a technology as a promising diagnostic tool for SARS-CoV-2
C Ortiz-Cartagena, L Fernández-García… - Microbiology …, 2022 - Am Soc Microbiol
At the end of 2019, a new coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), caused a pandemic that persists to date and has resulted in more than 6.2 …
(SARS-CoV-2), caused a pandemic that persists to date and has resulted in more than 6.2 …
Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review
JP Wilson, F Chowdhury, S Hassan, EP Harriss… - medRxiv, 2024 - medrxiv.org
Background Visceral leishmaniasis (VL) is a neglected tropical disease prevalent in
populations affected by poverty and poor nutrition. Without treatment, death is the norm …
populations affected by poverty and poor nutrition. Without treatment, death is the norm …
宏基因组二代测序在儿童内脏利什曼病相关噬血淋巴组织细胞增生症中的应用价值
康磊， 郭芳， 李立方， 白新凤， 程彩云… - 临床儿科杂志, 2023 - jcp.xinhuamed.com.cn
目的探讨宏基因组二代测序(mNGS) 在儿童内脏利什曼病(VL) 相关噬血淋巴组织细胞增生症(
HLH) 的临床价值. 方法回顾性分析2016 年1 月1 日至2022 年6 月30 日确诊的VL-HLH …
HLH) 的临床价值. 方法回顾性分析2016 年1 月1 日至2022 年6 月30 日确诊的VL-HLH …
RT-LAMP-CRISPR-Cas13a technology as a promising diagnostic tool for the SARS-CoV-2 virus
C Ortiz-Cartagena, L Fernández-García, L Blasco… - medRxiv, 2022 - medrxiv.org
At the end of 2019, the new coronavirus, SARS-CoV-2, began a pandemic that persists to
date and which has caused more than 6.2 million deaths. In the last couple of years …
date and which has caused more than 6.2 million deaths. In the last couple of years …